Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF. - Wikidata - awgldk - TriplyDB

Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF.

Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF.

http://www.wikidata.org/entity/Q35191520

about

Inflammation and its role in age-related macular degeneration NLRP3 Inflammasome and Pathobiology in AMD Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives.Inflammasomes Induced by 7-Ketocholesterol and Other Stimuli in RPE and in Bone Marrow-Derived Cells Differ Markedly in Their Production of IL-1β and IL-18.NLRP3 Upregulation in Retinal Pigment Epithelium in Age-Related Macular Degeneration Molecular Regulation of Sprouting Angiogenesis.The two faces of pannexins: new roles in inflammation and repair.

P2860

Q26768520-AB75A8D8-E4DA-4694-9FD8-A6AE1361BA98 Q26799766-53A17A29-B5A9-4F6A-9036-E240981F2B38 Q35001511-783552BE-C42F-416C-B6A0-0BAA00A9FA13 Q35161079-F14D1DD3-6C96-4B58-BBF0-1AF841C442FC Q36512570-1587643A-12F0-4ED5-A7EC-5563F583BF53 Q50423780-C0F4BD22-69FE-4105-AD62-87B2C56C8C04 Q55317709-B725CFD3-3451-41B2-A750-8D5CDD75C204

P2860

Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF.

http://www.wikidata.org/entity/Q35191520

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Interleukin-18 has antipermeab ...... iprocal suppression with VEGF.

@ast

Interleukin-18 has antipermeab ...... iprocal suppression with VEGF.

@en

type

label

Interleukin-18 has antipermeab ...... iprocal suppression with VEGF.

@ast

Interleukin-18 has antipermeab ...... iprocal suppression with VEGF.

@en

prefLabel

Interleukin-18 has antipermeab ...... iprocal suppression with VEGF.

@ast

Interleukin-18 has antipermeab ...... iprocal suppression with VEGF.

@en

P1433

Q35191520-A89CBE13-0301-4D21-8787-D65A6F7CE974

P1476

Q35191520-315641E1-EB8E-4E10-BB3F-59F2DB59517F

P2093

Q35191520-21C57C56-F2AD-4C5D-9980-50C1F6C94536

Q35191520-82EEAE94-0B1C-4577-A641-094F58854A30

Q35191520-B3C6D325-908C-4306-AE8C-E1E44D69D84F

Q35191520-C5C4C1DE-378A-4BDF-AA88-6EB632A805FC

Q35191520-DAA26AE1-18CB-424E-9D8A-B7B0CFC6153D

Q35191520-F3C9B9DB-8497-4452-80B5-339A97011513

P2860

Q35191520-0222169C-BD38-4309-8D90-ABC895FAC625

Q35191520-06A28AA0-F418-488B-B4AB-7FA2BB906FC8

Q35191520-0C27CB44-E4B1-4BEE-881D-72F1CD841E43

Q35191520-16E13CA2-2446-4B02-820F-A13CBF0669B5

Q35191520-2048964C-2827-4D1D-8B37-2920C1E17269

Q35191520-249E2116-3A2E-4D78-9005-16EDC17C5560

Q35191520-27639E4F-6923-4A69-924C-7C9F7642DB3A

Q35191520-2D2C2DB0-FD63-4EF4-B45C-AF207C84F3DE

Q35191520-2EF9EB3E-DCE0-4390-836C-090CBEB48F86

Q35191520-3C9DD305-0006-4761-B783-E58E8255D4DB

P304

Q35191520-C353CF17-D80E-419A-8D47-AAF349A255AB

P31

Q35191520-1c12c852-384e-427c-b2f4-1772b56739e9

Q35191520-641CF528-1131-4793-B3B2-1585A0011ECB

P356

Q35191520-4521E74B-232D-4CBF-8E02-2DFD5FDD13A5

P433

Q35191520-71040AD3-44E9-45F6-BC6A-F81604BF3236

P478

Q35191520-5E659640-8621-4508-A8C9-3A1FFD9A8CAD

P50

Q35191520-6088A4B0-C86B-4747-99EA-5849B3E35151

Q35191520-B44C9932-703F-4F98-97C7-1CF2477BC4BF

Q35191520-B9F2A217-F66F-4BE5-95C6-608BFAEC2B37

P577

Q35191520-AAFBB677-9330-43B4-BCC8-14BAE8CA7326

P698

Q35191520-C3062EBC-EFF8-4B06-A40C-DF258501483C

P932

Q35191520-03FD2BD2-68B1-4F23-B47D-F6954998802C

P356

P1433

Journal of Cellular Physiology

P1476

Interleukin-18 has antipermeab ...... iprocal suppression with VEGF.

@en

P2093

Gulnar Hafiz

http://www.w3.org/2001/XMLSchema#string

Jikui Shen

http://www.w3.org/2001/XMLSchema#string

Peter A Campochiaro

http://www.w3.org/2001/XMLSchema#string

Sean F Hackett

http://www.w3.org/2001/XMLSchema#string

Takeshi Iwase

http://www.w3.org/2001/XMLSchema#string

Tsunehiko Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence of IL-18 as a novel angiogenic mediator

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

ARPE-19, a human retinal pigment epithelial cell line with differentiated properties

Ranibizumab for neovascular age-related macular degeneration

NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin.

Interaction between bevacizumab and murine VEGF-A: a reassessment.

VEGF is major stimulator in model of choroidal neovascularization.

P304

974-983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.24575

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

229

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24515951

http://www.w3.org/2001/XMLSchema#string

P932

4364659

http://www.w3.org/2001/XMLSchema#string